Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00262938 · ClinicalTrials.gov registry record · NA

Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT00262938: Completed NA study, sponsored by Case Comprehensive Cancer Center.

NCT00262938 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00262938, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

RATIONALE: Exercise and dietary counseling may affect weight loss and improve the quality of life of obese endometrial cancer patients and may help them live longer and more comfortably. PURPOSE: This randomized clinical trial is studying the effects of exercise and dietary counseling on weight loss and quality of life of obese patients with stage I or stage II endometrial cancer in remission.

Interventions

  • PROCEDURE quality-of-life assessment
  • OTHER educational intervention
  • OTHER counseling intervention
  • BEHAVIORAL behavioral dietary intervention
  • OTHER preventative dietary intervention

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2005-02
Est. Completion 2011-08
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT00262938 record still lists

NCT00262938 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 5 interventions - of which quality-of-life assessment is the first listed.

NCT00262938 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00262938 about?

NCT00262938 is a clinical study titled "Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission". RATIONALE: Exercise and dietary counseling may affect weight loss and improve the quality of life of obese endometrial cancer patients and may help them live longer and more comfortably. PURPOSE: This randomized clinical trial is studying the effects of exercise and dietary counseling on weight los...

What is the current status of trial NCT00262938?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2005-02. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00262938?

The interventions under investigation include: quality-of-life assessment (PROCEDURE), educational intervention (OTHER), counseling intervention (OTHER), behavioral dietary intervention (BEHAVIORAL), preventative dietary intervention (OTHER).

Who is sponsoring clinical trial NCT00262938?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00262938's enrollment target sits among peer trials

47 1400th of 2000 higher than 599 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00262938, the US trial registry maintained by the National Library of Medicine. NCT00262938 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.